Supplementation With Vitamin D3 on Chronic Low Back Pain Patient
CompletedNot applicableNCT06082375
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The study was designed as a randomized double-blind placebo-controlled clinical trial with 8-week Vitamin D3 and physical activity intervention. The protocol was approved by Independent Bioethics Committee for Scientific Research at Medical University of Gdańsk (No. 525/2018), in accordance with the Declaration of Helsinki. We enrol 40 patient (aged ≥ 35), Patients diagnosed with chronic pain in the lumbar spine, qualified for surgical treatment at the Department of Neurosurgery Medicinal Unit in Gdańsk. Participation in the study was voluntary, and the condition for participation was obtaining informed consent from the patient.
Study details
- Official title
- Effect of 8-week Supplementation With Vitamin D3 on Functional and Cognitive Performance in Patients With Chronic Low Back Pain Eligible for Neurosurgery Intervention
- Conditions
- Interventions
- Dietary supplement: Vitamin D
- Dietary supplement: Placebo
- Sponsor
- Medical University of Gdansk
- Start date
- 2019-08-01
- Primary completion
- 2021-05-01
- Sex
- All
- Age range
- from 30 Years to 75 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Poland
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Pain in the lumbar spine that lasts more than 6 months (diagnosed by signs and symptoms, and tests such as magnetic resonance imaging (MRI)); * Failure to respond to medications and physical therapies; * Visual Analog Pain Scale (VAS), (0-100) score greater than or equal to 50; * Numerical Rating Scale (NRS); Exclusion Criteria: * Rheumatoid arthritis; * Diagnosed mental illness; * Drugs; * Metabolic bone diseases (hypo or hyperparasitism); * Chronic kidney diseases and diseases affecting vitamin D metabolism (stomach surgery, chronic liver diseases, kidney failure, malabsorption disorders, systemic infection, tumors, etc.) * Medicines that alter the metabolism of bones such as corticosteroids or bisphosphonates; * Vitamin D supplements in the last 3 months; * BMI: less than 19;
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06082375